000829949 001__ 829949
000829949 005__ 20220930130122.0
000829949 0247_ $$2doi$$a10.1016/j.bpj.2017.03.007
000829949 0247_ $$2ISSN$$a0006-3495
000829949 0247_ $$2ISSN$$a1542-0086
000829949 0247_ $$2WOS$$aWOS:000400505800010
000829949 0247_ $$2altmetric$$aaltmetric:19677191
000829949 0247_ $$2pmid$$apmid:28445753
000829949 037__ $$aFZJ-2017-03553
000829949 041__ $$aEnglish
000829949 082__ $$a570
000829949 1001_ $$0P:(DE-Juel1)145961$$aDammers, Christina$$b0$$ufzj
000829949 245__ $$aPyroglutamate-Modified Amyloid- β (3–42) Shows α -Helical Intermediates before Amyloid Formation
000829949 260__ $$aCambridge, Mass.$$bCell Press$$c2017
000829949 3367_ $$2DRIVER$$aarticle
000829949 3367_ $$2DataCite$$aOutput Types/Journal article
000829949 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1496726534_28738
000829949 3367_ $$2BibTeX$$aARTICLE
000829949 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000829949 3367_ $$00$$2EndNote$$aJournal Article
000829949 520__ $$aPyroglutamate-modified amyloid-β (pEAβ) has been described as a relevant Aβ species in Alzheimer’s-disease-affected brains, with pEAβ (3–42) as a dominant isoform. Aβ (1–40) and Aβ (1–42) have been well characterized under various solution conditions, including aqueous solutions containing trifluoroethanol (TFE). To characterize structural properties of pEAβ (3–42) possibly underlying its drastically increased aggregation propensity compared to Aβ (1–42), we started our studies in various TFE-water mixtures and found striking differences between the two Aβ species. Soluble pEAβ (3–42) has an increased tendency to form β-sheet-rich structures compared to Aβ (1–42), as indicated by circular dichroism spectroscopy data. Kinetic assays monitored by thioflavin-T show drastically accelerated aggregation leading to large fibrils visualized by electron microscopy of pEAβ (3–42) in contrast to Aβ (1–42). NMR spectroscopy was performed for backbone and side-chain chemical-shift assignments of monomeric pEAβ (3–42) in 40% TFE solution. Although the difference between pEAβ (3–42) and Aβ (1–42) is purely N-terminal, it has a significant impact on the chemical environment of >20% of the total amino acid residues, as revealed by their NMR chemical-shift differences. Freshly dissolved pEAβ (3–42) contains two α-helical regions connected by a flexible linker, whereas the N-terminus remains unstructured. We found that these α-helices act as a transient intermediate to β-sheet and fibril formation of pEAβ (3–42).
000829949 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000829949 588__ $$aDataset connected to CrossRef
000829949 7001_ $$0P:(DE-Juel1)161220$$aReiss, Kerstin$$b1
000829949 7001_ $$0P:(DE-Juel1)145165$$aGremer, Lothar$$b2$$ufzj
000829949 7001_ $$0P:(DE-Juel1)132010$$aLecher, Justin$$b3
000829949 7001_ $$0P:(DE-Juel1)162487$$aZiehm, Tamar$$b4$$ufzj
000829949 7001_ $$0P:(DE-Juel1)132023$$aStoldt, Matthias$$b5$$ufzj
000829949 7001_ $$0P:(DE-Juel1)132019$$aSchwarten, Melanie$$b6$$ufzj
000829949 7001_ $$0P:(DE-Juel1)132029$$aWillbold, Dieter$$b7$$eCorresponding author$$ufzj
000829949 773__ $$0PERI:(DE-600)1477214-0$$a10.1016/j.bpj.2017.03.007$$gVol. 112, no. 8, p. 1621 - 1633$$n8$$p1621 - 1633$$tBiophysical journal$$v112$$x0006-3495$$y2017
000829949 8564_ $$uhttps://juser.fz-juelich.de/record/829949/files/PIIS0006349517302965.pdf$$yRestricted
000829949 8564_ $$uhttps://juser.fz-juelich.de/record/829949/files/PIIS0006349517302965.gif?subformat=icon$$xicon$$yRestricted
000829949 8564_ $$uhttps://juser.fz-juelich.de/record/829949/files/PIIS0006349517302965.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000829949 8564_ $$uhttps://juser.fz-juelich.de/record/829949/files/PIIS0006349517302965.jpg?subformat=icon-180$$xicon-180$$yRestricted
000829949 8564_ $$uhttps://juser.fz-juelich.de/record/829949/files/PIIS0006349517302965.jpg?subformat=icon-640$$xicon-640$$yRestricted
000829949 8564_ $$uhttps://juser.fz-juelich.de/record/829949/files/PIIS0006349517302965.pdf?subformat=pdfa$$xpdfa$$yRestricted
000829949 8767_ $$92017-05-12$$d2017-05-12$$ePage charges$$jZahlung erfolgt$$lKK: Barbers$$p8086$$zDartmouth J. Service
000829949 8767_ $$92017-05-12$$d2017-05-12$$eColour charges$$jZahlung erfolgt$$lKK: Barbers$$p8086$$zDartmouth J. Service
000829949 8767_ $$92017-05-12$$d2017-05-12$$eOther$$jZahlung erfolgt$$lKK: Barbers$$p8086$$zCredit card fee
000829949 909CO $$ooai:juser.fz-juelich.de:829949$$pOpenAPC$$pVDB$$popenCost
000829949 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145961$$aForschungszentrum Jülich$$b0$$kFZJ
000829949 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145165$$aForschungszentrum Jülich$$b2$$kFZJ
000829949 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)162487$$aForschungszentrum Jülich$$b4$$kFZJ
000829949 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132023$$aForschungszentrum Jülich$$b5$$kFZJ
000829949 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132019$$aForschungszentrum Jülich$$b6$$kFZJ
000829949 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132029$$aForschungszentrum Jülich$$b7$$kFZJ
000829949 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000829949 9141_ $$y2017
000829949 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBIOPHYS J : 2015
000829949 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000829949 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000829949 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000829949 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000829949 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000829949 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000829949 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000829949 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000829949 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000829949 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000829949 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie $$x0
000829949 9801_ $$aAPC
000829949 980__ $$ajournal
000829949 980__ $$aVDB
000829949 980__ $$aI:(DE-Juel1)ICS-6-20110106
000829949 980__ $$aAPC
000829949 980__ $$aUNRESTRICTED
000829949 981__ $$aI:(DE-Juel1)IBI-7-20200312